Cargando…
地西他滨联合预激方案治疗53例复发难治正常核型急性髓系白血病的疗效分析
OBJECTIVE: To study clinical characteristics of refractory or relapsed DNMT3A(+) cytogenetically normal acute myeloid leukemia (CN-AML) patients, and to explore the overall response rate (ORR) and side effects of these patients followed the therapy including decitabine with CAG or CAG-like regimen....
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342321/ https://www.ncbi.nlm.nih.gov/pubmed/26759106 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.12.010 |
Ejemplares similares
-
西达本胺、地西他滨联合CHAG方案治疗复发难治性急性髓系白血病八例疗效分析
Publicado: (2018) -
地西他滨单药与CAG/HAG方案治疗难治性贫血伴有原始细胞增多的疗效和安全性比较
Publicado: (2017) -
地西他滨10天方案治疗初治老年急性髓系白血病的疗效及安全性初步探讨
Publicado: (2016) -
异基因造血干细胞移植后复发急性髓系白血病患者地西他滨治疗前后免疫学变化
Publicado: (2020) -
地西他滨联合半量CAG方案治疗骨髓增生异常综合征伴原始细胞增多和急性髓系白血病伴骨髓增生异常相关改变
Publicado: (2018)